Synergistic Effect between Erlotinib and MEK Inhibitors in KRAS Wild-Type Human Pancreatic Cancer Cells (Q35691935)
scientific article published on March 8, 2011
Language:
(P31) (Q13442814)
(P50) (Q59694377)
(P304) 2744-2756
(P407) (Q1860)
(P433) 9
(P478) 17
(P577) Tuesday, March 8, 2011
(P921) (Q212961)
(Q418369)
(P953) https://aacrjournals.org/clincancerres/article-pdf/17/9/2744/2003493/2744.pdf
https://europepmc.org/articles/PMC3265169
https://europepmc.org/articles/PMC3265169?pdf=render
https://doi.org/10.1158/1078-0432.ccr-10-2214
https://aacrjournals.org/clincancerres/article-pdf/17/9/2744/2003493/2744.pdf
(P1433) (Q332253)
(P1476) "Synergistic effect between erlotinib and MEK inhibitors in KRAS wild-type human pancreatic cancer cells" (language: en)
"Synergistic Effect between Erlotinib and MEK Inhibitors in KRAS Wild-Type Human Pancreatic Cancer Cells" (language: en)
(P2093) Ashish Choudhary
Haiyong Han
Ruben M. Munoz
Daniel D. Von Hoff
(P2860) (Q34617300)
(Q27659493)
(Q39763382)
(Q39799421)
(Q27657185)
(Q24657439)
(Q39869672)
(Q37396680)
(Q37113682)
(Q39929011)
(Q24653018)
(Q39976736)
(Q36756298)
(Q27851426)
(Q27851422)
(Q36026392)
(Q40093939)
(Q24306894)
(Q29619344)
(Q36610301)
(Q40158493)
(Q40164535)
(Q40169788)
(Q24633878)
(Q40240288)
(Q40296336)
(Q29615133)
(Q40328353)
(Q28272767)
(Q40392798)
(Q36064490)
(Q40486808)
(Q35936438)
(Q38445646)
(Q34550827)
(Q24645514)
(Q35581817)
(Q40662652)
(Q35747777)
(Q25938999)
(Q40912414)
(Q41648568)
(Q34387450)
(Q40855958)
(Q35833155)
(Q24682187)
(Q39720116)
(Q43152544)
(Q37396608)
(Q40033557)
(Q46903224)
(Q38432430)
(Q52085365)
(Q45000490)
(Q44280921)
(Q44253349)
(Q43658492)
(Q57281056)
(Q74592755)
(Q80429745)
other details
description scientific article published on March 8, 2011

External Links